Discovery of Tumor Reactive T Cell Receptors in Newly Diagnosed Multiple Myeloma
Mirco Friedrich(Broad Institute), Marc S. Raab(Unknown), Lilli Sophie Sester(Heidelberg University), Katharina A.M. Lindner(German Cancer Research Center), Lukas Bunse(German Cancer Research Center), Carsten Müller‐Tidow(Heidelberg University), Simon Steiger(German Cancer Research Center), Alexandra M. Poos(German Cancer Research Center), Edward W. Green(German Cancer Research Center), Julius Michel(German Cancer Research Center), Stefan B. Eichmüller(German Cancer Research Center), Niels Weinhold(German Cancer Research Center), Hartmut Goldschmidt(Heidelberg University), Karsten Rippe(German Cancer Research Center), Paola Neri(University of Calgary), Michael Platten(German Cancer Research Center), Nizar J. Bahlis(Institute of Cancer Research), Nina Prokoph(MRC Laboratory of Molecular Biology), Raphael Lutz(German Cancer Research Center), Tim Robin Wagner(German Cancer Research Center), Niklas Kehl(German Cancer Research Center), Michael Kilian(German Cancer Research Center), Lukas John(University of Hohenheim), Sebastian Uhrig(German Cancer Research Center), Stefan Fröhling(German Cancer Research Center)
Cited by 0
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k